MARKET

GLPG

GLPG

Galapagos
NASDAQ

Real-time Quotes | Nasdaq Last Sale

190.13
+4.57
+2.46%
After Hours: 190.13 0 0.00% 16:00 08/12 EDT
OPEN
185.44
PREV CLOSE
185.56
HIGH
190.26
LOW
184.68
VOLUME
86.06K
TURNOVER
--
52 WEEK HIGH
274.03
52 WEEK LOW
112.00
MARKET CAP
12.41B
P/E (TTM)
242.33
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 10 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average GLPG stock price target is 220.09 with a high estimate of 299.74 and a low estimate of 148.88.

EPS

GLPG News

More
Scipher Medicine And Galapagos Sign Collaboration In Inflammatory Bowel Disease
-- Companies to jointly validate novel drug targets -- -- Scipher eligible for upfront, opt-in and milestone payments -- -- Galapagos to progress selected targets into drug discovery -- Mechelen, Belgium and Boston,
Companies to jointly validate novel drug targets -- -- Scipher eligible for upfront, opt-in and milestone payments -- -- Galapagos to progress selected targets into drug discovery -- Mechelen, Belgium and Boston, · 3h ago
Morgan Stanley Maintains Equal-Weight on Galapagos, Lowers Price Target to $221
Morgan Stanley maintains Galapagos (NASDAQ:GLPG) with a Equal-Weight and lowers the price target from $224 to $221.
Benzinga · 2d ago
Galapagos reports 1H results
Galapagos (NASDAQ:GLPG): 1H GAAP EPS of -€2.55. Revenues and other income of €224.6M (+107.0% Y/Y) Press Release
seekingalpha · 5d ago
Galapagos reports solid H1 2020 progress
* First half-year 2020 financial results: * Group revenues and other income of €224.6 million * Operating loss of €130.8 million * Net loss of €165.6 million * Cash and current financial investments on 30 June 2020 of €5.6 billion * Positive CHMP
GlobeNewswire · 6d ago
3 Biotech Stocks With Big Incoming Catalysts
MotleyFool.com · 07/25 04:00
European advisory group backs Gilead/Galapagos' filgotinib for rheumatoid arthritis
The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval of Gilead Sciences (NASDAQ:GILD) and collaboration
seekingalpha · 07/24 17:33
GILEAD  AND  GALAPAGOS  ANNOUNCE  POSITIVE  EUROPEAN  CHMP  OPINION  FOR  JYSELECA®  (FILGOTINIB)  FOR  THE  TREATMENT  OF  ADULTS  WITH  MODERATE  TO  SEVERE  RHEUMATOID  ARTHRITIS
\-- Clinical Development Program of Filgotinib Demonstrated Durable Efficacy Balanced with a Consistent Safety Profile in Rheumatoid Arthritis Through 52 Weeks -- Foster City, Calif., and Mechelen, Belgium, July 24 2020, 14:10 CET; regulated information – Gil
GlobeNewswire · 07/24 12:14
Gilead, Galapagos Report Positive CHMP Opinion for Jyseleca For Treatment Of Adults With Moderate To Severe Rheumatoid Arthritis
Benzinga · 07/24 12:11

Industry

Biotechnology & Medical Research
+0.70%
Pharmaceuticals & Medical Research
+1.61%

Hot Stocks

Symbol
Price
%Change

About GLPG

Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company aims to develop a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. In addition, the Company’s mission is to develop a number of medicines based on the discovery of novel targets. Galapagos NV also discovers which proteins that are involved in causing diseases such as, rheumatoid, arthritis, inflammatory bowel disease and fibrosis. Galapagos aims to develop small molecules that inhibit these targets, restore the balance and thereby positively influence the course of the disease.
More

Webull offers kinds of Galapagos NV stock information, including NASDAQ:GLPG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GLPG stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GLPG stock methods without spending real money on the virtual paper trading platform.